WCBA
CL icon

Weaver C. Barksdale & Associates’s Colgate-Palmolive CL Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,390
Closed -$367K – 549
2014
Q2 		$367K Hold
5,390
– – 0.3% 89
2014
Q1 		$350K Hold
5,390
– – 0.29% 89
2013
Q4 		$351K Sell
5,390
-50
-0.9% -$3.2K 0.29% 89
2013
Q3 		$323K Buy
5,440
+5,175
+1,953% +$307K 0.3% 86
2013
Q2 		$15K Buy
+265
New +$15.7K 0.01% 204

Other funds holding CL

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Weaver C. Barksdale & Associates's CL Position: Q3 2014 in Review

Weaver C. Barksdale & Associates sold out of Colgate-Palmolive (CL) in Q3 2014, closing a stake of 5,390 shares — an estimated $367K sold.

Weaver C. Barksdale & Associates first reported a position in CL in Q2 2013 and held it in 5 quarters. The position peaked at $367K in Q2 2014. 1,191 funds tracked by Wall St. Rank hold CL as of Q3 2014.

  • Weaver C. Barksdale & Associates reported no remaining Colgate-Palmolive position as of Q3 2014 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 5,390 Colgate-Palmolive shares in Q3 2014, an estimated $367K.
  • Weaver C. Barksdale & Associates first reported a position in Colgate-Palmolive in Q2 2013 and held it in 5 quarters.
  • Weaver C. Barksdale & Associates's Colgate-Palmolive position peaked at $367K in Q2 2014.
  • 1,191 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2014.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2014, filed 27 Oct 2014.